Healthcare -
Biotechnology - NASDAQ - US
$ 18.76
-0.875 %
$ 1.89 B
Market Cap
-3.69
P/E
BEAM - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities BEAM - Beam Therapeutics Inc.
185 M
LAST VALUE
54.95%
2 YEAR CAGR
36.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR